NCT00100646View on ClinicalTrials.gov

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
HIV Infections
Interventions
BEHAVIORAL

Structured treatment interruption

Interruptions in treatment will last 2, 4, and 8 weeks in between 16-week periods of ART

DRUG

Lamivudine

300 mg tablet taken orally daily

DRUG

Lopinavir/Ritonavir

400 mg lopinavir/100 mg ritonavir tablet taken orally twice daily

DRUG

Stavudine

Dosage dependent on weight

BIOLOGICAL

Rabies de novo antigen

Vaccine injected intramuscularly

Trial Locations (1)

Unknown

University of the Witwatersrand, Johannesburg

All Listed Sponsors
lead

The Wistar Institute

OTHER

NCT00100646 - Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa | Biotech Hunter | Biotech Hunter